Table 2.
Plasma risk markers in nested case control study where subjects were not on warfarin
| Cases (n = 48) | Controls (n = 93) | Odds ratio (95% CI) | P-value | |
|---|---|---|---|---|
| Factor VIII (iu/dL) | 158.4 (42.0) | 144.6 (38.2) | 1.52 (1.01, 2.28) | 0.044 |
| Fibrinogen (g/L) | 3.60 (0.61) | 3.73 (0.79) | 0.81 (0.54, 1.24) | 0.34 |
| PAI-1 (ng/mL) | 58.5 (35.9) | 58.8 (30.9) | 0.97 (0.68, 1.38) | 0.86 |
| IGF-1 (ng/mL) | 74.0 (19.2) | 76.0 (24.3) | 0.92 (0.63, 1.34) | 0.66 |
| Factor VII (iu/dL) | 135.0 (32.8) | 137.9 (32.5) | 0.85 (0.56, 1.29) | 0.45 |
| Factor IX (iu/dL) | 138.6 (30.0) | 140.4 (26.8) | 0.94 (0.66, 1.33) | 0.72 |
| APC ratio | 3.83 (1.19) | 3.87 (1.12) | 0.96 (0.66, 1.40) | 0.85 |
Means (SD) are shown. Unadjusted odds ratios for continuous variables with approximately 1 SD change (SD in control group) are shown.